Diabetes and Other Neurogenic Underactive Bladder Conditions
Patients UAB criteria UAB % Predictors Kaplan et al. (1995) 115 M, 68 F, between 48 and 93 years old, with voiding symptoms Impaired detrusor contractility: poorly sustained or…
Novel Drugs for Underactive Bladder
Fig. 7.1 Potential new drugs for UAB target key molecular pathways involved in micturition control at the levels of the urothelium, detrusor muscle autonomic and afferent pathways, spinal cord, and…
Geriatric Urology and Underactive Bladder
Comorbid condition Direct and indirect effects Benign prostatic hyperplasia (BPH) Bladder outlet obstruction Cognitive impairment (delirium, dementia) Decreased sensation of filling Reduced awareness of need to void Diabetes mellitus Decreased…
Current Drug Therapy for Underactive Bladder
Fig. 6.1 Direct (bethanechol) and indirect (distigmine) agonist treatment of underactive bladder Current approaches toward medical treatment of UAB aim at providing additional stimulation of bladder muscarinic receptors. This can…
